Investor Optimism Abounds Bluestar Adisseo Company (SHSE:600299) But Growth Is Lacking
With a median price-to-sales (or "P/S") ratio of close to 2.4x in the Chemicals industry in China, you could be forgiven for feeling indifferent about Bluestar Adisseo Company's (SHSE:600299) P/S ratio of 2x. However, investors might be overlooking a clear opportunity or potential setback if there is no rational basis for the P/S.
Check out our latest analysis for Bluestar Adisseo
What Does Bluestar Adisseo's P/S Mean For Shareholders?
Bluestar Adisseo certainly has been doing a good job lately as it's been growing revenue more than most other companies. Perhaps the market is expecting this level of performance to taper off, keeping the P/S from soaring. If not, then existing shareholders have reason to be feeling optimistic about the future direction of the share price.
If you'd like to see what analysts are forecasting going forward, you should check out our free report on Bluestar Adisseo.Is There Some Revenue Growth Forecasted For Bluestar Adisseo?
The only time you'd be comfortable seeing a P/S like Bluestar Adisseo's is when the company's growth is tracking the industry closely.
If we review the last year of revenue growth, the company posted a worthy increase of 12%. Revenue has also lifted 21% in aggregate from three years ago, partly thanks to the last 12 months of growth. Therefore, it's fair to say the revenue growth recently has been respectable for the company.
Turning to the outlook, the next year should generate growth of 7.3% as estimated by the three analysts watching the company. That's shaping up to be materially lower than the 25% growth forecast for the broader industry.
With this information, we find it interesting that Bluestar Adisseo is trading at a fairly similar P/S compared to the industry. It seems most investors are ignoring the fairly limited growth expectations and are willing to pay up for exposure to the stock. These shareholders may be setting themselves up for future disappointment if the P/S falls to levels more in line with the growth outlook.
The Bottom Line On Bluestar Adisseo's P/S
It's argued the price-to-sales ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.
Given that Bluestar Adisseo's revenue growth projections are relatively subdued in comparison to the wider industry, it comes as a surprise to see it trading at its current P/S ratio. When we see companies with a relatively weaker revenue outlook compared to the industry, we suspect the share price is at risk of declining, sending the moderate P/S lower. Circumstances like this present a risk to current and prospective investors who may see share prices fall if the low revenue growth impacts the sentiment.
And what about other risks? Every company has them, and we've spotted 1 warning sign for Bluestar Adisseo you should know about.
If companies with solid past earnings growth is up your alley, you may wish to see this free collection of other companies with strong earnings growth and low P/E ratios.
Valuation is complex, but we're here to simplify it.
Discover if Bluestar Adisseo might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SHSE:600299
Bluestar Adisseo
Engages in the research, development, production, and sale of feed additives for animal nutrition worldwide.
Excellent balance sheet with proven track record.